Laws of Malaysia·Act 678
BIOSAFETY ACT 2007
AKTA BIOKESELAMATAN 2007
Official editions
View on the Attorney-General's Chambers portal (lom.agc.gov.my)Business activities this Act regulates
We haven't mapped this Act to specific MSIC business activities. Many federal Acts are general statutes (company law, employment, taxation, procedure) that apply across business activities generally rather than regulating one industry. Where an Act governs a specific licence, the regulated activities appear here.
Consolidated text (extract)
LAWS OF MALAYSIA
ONLINE VERSION OF UPDATED
TEXT OF REPRINT
Act 678
BIOSAFETY ACT 2007
As at 1 May 2019
2
BIOSAFETY ACT 2007
…
…
…
29 August 2007
Date of publication in the Gazette
…
…
30 August 2007
Latest amendment made by
P. U. (A) 36/2019 which came
into operation on
…
…
…
16 February 2019
Date of Royal Assent
3
LAWS OF MALAYSIA
Act 678
BIOSAFETY ACT 2007
ARRANGEMENT OF SECTIONS
PART I
PRELIMINARY
Section
1.
Short title and commencement
2.
Act to be read together with other laws
3.
Interpretation
PART II
NATIONAL BIOSAFETY BOARD
4.
Establishment of the National Biosafety Board
5.
Functions of the Board
6.
Establishment of the Genetic Modification Advisory Committee
7.
Board and Advisory
subcommittees
8.
Appointment of Director General and other officers
9.
Delegation of functions of the Board
Committee
may
establish
10. Power of Minister to give directions
PART III
APPROVAL FOR RELEASE AND IMPORT
11. Application of Part III
committees
and
4
Laws of Malaysia
ACT 678
Section
12. Requirement for approval
13. Application for approval
14. Director General to refer application to Advisory Committee, etc.
15. Advisory Committee to make recommendations on application for approval
16. Approval for release and import
17. Approval to be valid for subsequent release and import
18. Review of approval upon obtaining new information
19. Circumstances where Board may make further order on approval
20. Appeal to Minister relating to approval
PART IV
NOTIFICATION FOR EXPORT, CONTAINED USE AND IMPORT
FOR CONTAINED USE
21. Application of Part IV
22. Requirement for notification
23. Compliance with requirements of importing country
24. Submission of notification
25. Acknowledgement of submission of notification by Director General
26. Specific measures to be taken in contained use
27. Director General may require additional information
28. Director General to refer notification to Advisory Committee and relevant
agency
29. Advisory Committee to make recommendations on notification
30. Board to make appropriate order on notification
31. Board may require additional information
32. Review of notification upon obtaining new information
33. Circumstances where Board may make further order on notification
34. Appeal to Minister relating to notification
35. Taking of decision by the Board or Minister
Biosafety
5
PART IV
RISK ASSESSMENT AND RISK MANAGEMENT REPORTS AND
EMERGENCY RESPONSE PLAN
Section
36. Risk assessment and risk management reports
37. Emergency response plan
PART VI
ENFORCEMENT
38. Enforcement officers
39. Power of investigation
40. Search by warrant
41. Search without warrant
42. Access to computerized data
43. List of things seized
44. Power to seal premises
45. Forfeiture of living modified organisms or products of such organisms, etc.
46. Cost of holding organisms, etc., seized
47. No costs or damages arising from entry, search or seizure to be recoverable
48. Obstruction of enforcement officers
49. Examination of persons acquainted with case
49A. Admissibility of statement of evidence
50. Power to require production of things related to offence
51. Enforcement officer may seek assistance to examine things related to
offence
52. Power of Board to require information on living modified organisms or
products of such organisms
53. Power to take sample
54. Procedure for taking sample
55. Appointment of analyst
6
Laws of Malaysia
Section
56. Certificate of analysis
57. Presumption
58. Institution of prosecution
PART VII
MISCELLANEOUS
59. Confidential business information
60. Public disclosure
61. Identification and labelling
62. Assistance from multi-agencies in emergency
63. Service of notice
64. Offence by body corporate
65. Offence by partner, agent or servant
66. Power to compound
67. Falsification, concealment and destruction of document
68. Power of Minister to exempt
69. Power to make regulations
70. Power to amend Schedules
71. Transitional provisions
FIRST SCHEDULE
SECOND SCHEDULE
THIRD SCHEDULE
ACT 678
7
LAWS OF MALAYSIA
Act 678
BIOSAFETY ACT 2007
An Act to establish the National Biosafety Board; to regulate the
release, importation, exportation and contained use of living modified
organisms, and the release of products of such organisms, with the
objectives of protecting human, plant and animal health, the
environment and biological diversity, and where there are threats of
irreversible damage, lack of full scientific evidence may not be used as
a reason not to take action to prevent such damage; and to provide for
matters connected therewith.
[1 December 2009, P.U. (B) 537/2009]
ENACTED by the Parliament of Malaysia as follows:
PART I
PRELIMINARY
Short title and commencement
1. (1)
This Act may be cited as the Biosafety Act 2007.
(2) This Act comes into operation on a date to be appointed by the
Minister by notification in the Gazette.
Act to be read together with other laws
2. (1) This Act shall be read together with any other written law
relating to import and export, human, plant and animal health, the
environment and biological diversity, and the provisions of this Act
8
Laws of Malaysia
ACT 678
shall be in addition to, and not in derogation of, the provisions of such
other written laws.
(2) In the event of any inconsistencies between the provisions of
this Act and any of the other written laws referred to in subsection (1)
the provisions of this Act shall prevail.
Interpretation
3. In this Act, unless the context otherwise requires—
“release activity” means any intentional introduction of living
modified organisms or products of such organisms into the
environment through the activities or for the purposes specified in the
Second Schedule;
“modern biotechnology” means the application of—
(a)
in vitro nucleic acid techniques, including recombinant
deoxyribonucleic acid (DNA) and direct injection of the
nucleic acid into cells or organelles; or
(b)
fusion of cells beyond the taxonomic family,
that overcome natural physiological reproductive or recombination
barriers and that are not techniques used in traditional breeding and
selection;
“products of such organisms” means any product derived from a
living modified organism or part of a living modified organism—
(a)
if the product contains detectable
deoxyribonucleic acid (DNA); or
recombinant
(b)
where the profile, characteristic or properties of the
product is or are no longer equivalent to its conventional
counterpart irrespective of the presence of the
recombinant deoxyribonucleic acid (DNA);
Biosafety
9
“Advisory Committee” means the Genetic Modification Advisory
Committee established under section 6;
“analyst” means an analyst appointed under section 55;
“contained use” means any operation including research and
development, production or manufacturing operation involving living
modified organisms, or storage of living modified organisms,
undertaken within a facility, installation or other physical structure
such that it prevents the contact and impact of the living modified
organisms on the external environment;
“approval” means an approval granted under subsection 16(3);
“biological diversity” means the variability among living organisms
from all sources including, inter alia, terrestrial, marine and other
aquatic ecosystems and the ecological complexes of which they are
part; and includes diversity within species, between species and of
ecosystems;
“Director General” means the Director General appointed under
subsection 8(1);
“Board” means the National Biosafety Board established under
subsection 4(1);
“Minister” means the Minister charged with the responsibility for
natural resources and environment;
“approved person” means—
(a)
a person to whom an approval has been granted under
Part III; or
(b)
a person to whom an acknowledgement of receipt on the
submission of a notification under Part IV has been
issued;
10
Laws of Malaysia
ACT 678
“living modified organism” means any living organism that
possesses a novel combination of genetic material obtained through the
use of modern biotechnology;
“living organism” means any biological entity capable of transferring
or replicating genetic material, including sterile organisms, viruses and
viroids;
“enforcement officer” means an enforcement officer appointed under
subsection 8(1) and includes an officer specified in the Third Schedule
and an officer authorized under paragraph 38(c);
“occupier” means a person in actual occupation or having the charge,
management or control of—
(a)
any premises; or
(b)
in relation to premises where different parts of which are
occupied by different persons, the respective persons in
occupation or control of each part;
“Chairman” means the Chairman of the Board appointed under
paragraph 4(2)(a);
“premises” includes houses, buildings, lands, tenements, easements
of any tenure, whether open or enclosed, whether built on or not,
whether public or private, and whether maintained or not under
statutory authority and any machinery, plant, vessel, aircraft or other
vehicle.
PART II
NATIONAL BIOSAFETY BOARD
Establishment of the National Biosafety Board
4. (1) A board by the name of the “National Biosafety Board” is
established.
Biosafety
11
(2) The Board shall consist of the following members who shall be
appointed by the Minister:
(3)
(a)
the Secretary General of the Ministry of Water, Land and
Natural Resources who shall be the Chairman;
(b)
a representative from the Ministry of Agriculture and
Agro-based Industry;
(c)
a representative from the Ministry of Health;
(d)
a representative from the Ministry of Primary Industries;
(e)
a representative from the Ministry of Domestic Trade and
Consumer Affairs;
(f)
a representative from the Ministry of International Trade
and Industry;
(g)
a representative from the Ministry of Energy, Science,
Technology, Environment and Climate Change; and
(h)
not more than four other persons who have the knowledge
or experience or both in any of the disciplines or matters
relevant to this Act.
The provisions of the First Schedule shall apply to the Board.
(4) The Director General shall be the Secretary of the Board and
shall carry out such duties as may be imposed by the Board.
(5)
The Board shall be responsible to the Minister.
Functions of the Board
5. (1)
The functions of the Board shall be as follows:
12
Laws of Malaysia
ACT 678
(a)
to decide on all applications and matters under Part III
and Part IV;
(b)
to monitor activities relating to living modified organisms
and products of such organisms;
(c)
to promote research, development, educational and
training activities relating to biosafety;
(d)
to establish mechanisms to facilitate the collection,
storage and dissemination of data relating to living
modified organisms and products of such organisms and
biosafety; and
(e)
where so directed by the Minister, to perform or provide
for the performance of the obligations arising from
agreements, conventions or treaties relating to biosafety
to which Malaysia is a party where such agreements,
conventions or treaties relate to the purposes of this Act.
(2) The Board shall have power to do such things as the Board
thinks fit to enable it to perform its functions effectively or which are
incidental to the performance of its functions.
Establishment of the Genetic Modification Advisory Committee
6. (1) A committee by the name of the “Genetic Modification
Advisory Committee” is established.
(2) The function of the Advisory Committee is to provide
scientific, technical and other relevant advice to the Minister or the
Board.
(3) The chairman of the Advisory Committee shall be appointed
by the Minister.
(4) Such number, as may be approved by the Minister, of other
members of the Advisory Committee shall be appointed by the Board.
Biosafety
13
(5) Members of the Advisory Committee shall consist of experts
from various science-based and other relevant disciplines.
(6) The chair
Extract truncated for display. Download the official PDF above for the full text.